Breathalyzer Test May Detect Deadliest Cancer — Researchers from TAU and partner institutions develop groundbreaking device that spots lung cancer – to stop it in its tracks – A new device developed by a team of Israeli, American, and British cancer researchers may turn the tide by both accurately detecting lung cancer and identifying its stage of progression.
The mammography dilemma — Complex benefits and harms of mammography require individualized approach – A comprehensive review of 50 year’s worth of international studies assessing the benefits and harms of mammography screening suggests that the benefits of the screening are often overestimated, while harms are underestimated.
Research backs risk-reduction surgery for ovarian cancer – Scientists back preventative surgery to improve survival for women who are at greater risk of getting ovarian cancer and suggest it appears helpful for women at risk of getting breast cancer because of genetic faults.
5 Reasons that Breast Augmentation is the Top Cosmetic Surgery — Plastic surgeon Dr. Emily J. Kirby discusses why women choose breast enhancement with confidence – Year in and year out, breast augmentation continues to be a popular cosmetic surgery for women. According to statistics from the American Society of Plastic Surgeons (ASPS), it has been the top plastic surgery in the United States since 2006.
Major Changes Urged for Cancer Screening and Treatment — Scientific Panel Recommends New Personalized Strategies to Reduce Cancer Overtreatment – To address the growing problem of people being overdiagnosed and overtreated for cancer, a group of scientists convened by the National Cancer Institute and chaired by a UC San Francisco breast cancer expert is proposing a major update of the way the nation approaches diseases now classified as “cancer.”
US FDA approves Lymphoseek to help locate lymph nodes in patients with certain cancers – breast cancer & melanoma – The U.S. Food and Drug Administration approved Lymphoseek (technetium Tc 99m tilmanocept) Injection, a radioactive diagnostic imaging agent that helps doctors locate lymph nodes in patients with breast cancer or melanoma who are undergoing surgery to remove tumor-draining lymph nodes.
Heart disease risk after breast cancer radiotherapy smaller than previously thought – Researchers have for the first time calculated by how much radiotherapy for breast cancer increases the risk of heart disease and the findings can now be used by doctors to help treat patients more appropriately.
U of M researchers find wide variation in cesarean delivery rates among US hospitals – Cesarean delivery is the most common surgery in the United States, performed on 1.67 million American women annually. The latest study, appearing in Health Affairs, shows that cesarean delivery rates varied tenfold across U.S. hospitals, from 7.1 percent to 69.9 percent.
FDA approves new silicone gel-filled breast implant — Agency requires post-approval safety studies to assess rare events – The U.S. Food and Drug Administration approved the Natrelle 410 Highly Cohesive Anatomically Shaped Silicone-Gel Filled Breast Implant to increase breast size (augmentation) in women at least 22 years old and to rebuild breast tissue (reconstruction) in women of any age. Natrelle 410 implants are manufactured by Allergan, Inc.